Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells
- PMID: 15657067
- DOI: 10.1074/mcp.M400118-MCP200
Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells
Abstract
Overexpression and enhanced activation of the epidermal growth factor (EGF) receptor are frequent events in human cancers that correlate with poor prognosis. Anti-phosphotyrosine and anti-EGFr affinity chromatography, isotope-coded muLC-MS/MS, and immunoblot methods were combined to describe and measure signaling networks associated with EGF receptor activation and pharmacological inhibition. The squamous carcinoma cell line HN5, which overexpresses EGF receptor and displays sustained receptor kinase activation, was used as a model system, where pharmacological inhibition of EGF receptor kinase by erlotinib markedly reduced auto and substrate phosphorylation, Src family phosphorylation at EGFR Y845, while increasing total EGF receptor protein. Diverse sets of known and poorly described functional protein classes were unequivocally identified by affinity selection, comprising either proteins tyrosine phosphorylated or complexed therewith, predominantly through EGF receptor and Src family kinases, principally 1) immediate EGF receptor signaling complexes (18%); 2) complexes involved in adhesion and cell-cell contacts (34%); and 3) receptor internalization and degradation signals. Novel and known phosphorylation sites could be located despite the complexity of the peptide mixtures. In addition to interactions with multiple signaling adaptors Grb2, SHC, SCK, and NSP2, EGF receptors in HN5 cells were shown to form direct or indirect physical interactions with additional kinases including ACK1, focal adhesion kinase (FAK), Pyk2, Yes, EphA2, and EphB4. Pharmacological inhibition of EGF receptor kinase activity by erlotinib resulted in reduced phosphorylation of downstream signaling, for example through Cbl/Cbl-B, phospholipase Cgamma (PLCgamma), Erk1/2, PI-3 kinase, and STAT3/5. Focal adhesion proteins, FAK, Pyk2, paxillin, ARF/GIT1, and plakophillin were down-regulated by transient EGF stimulation suggesting a complex balance between growth factor induced kinase and phosphatase activities in the control of cell adhesion complexes. The functional interactions between IGF-1 receptor, lysophosphatidic acid (LPA) signaling, and EGF receptor were observed, both direct and/or indirectly on phospho-Akt, phospho-Erk1/2, and phospho-ribosomal S6.
Similar articles
-
Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.J Biol Chem. 1998 Sep 4;273(36):23110-7. doi: 10.1074/jbc.273.36.23110. J Biol Chem. 1998. PMID: 9722539
-
The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.Mol Pharmacol. 2005 Jan;67(1):184-94. doi: 10.1124/mol.104.003533. Epub 2004 Oct 1. Mol Pharmacol. 2005. PMID: 15465928
-
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.J Biol Chem. 2003 May 23;278(21):18902-13. doi: 10.1074/jbc.M300939200. Epub 2003 Mar 14. J Biol Chem. 2003. PMID: 12642595
-
Cellular functions regulated by phosphorylation of EGFR on Tyr845.Int J Mol Sci. 2013 May 23;14(6):10761-90. doi: 10.3390/ijms140610761. Int J Mol Sci. 2013. PMID: 23702846 Free PMC article. Review.
-
Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.Breast Cancer Res. 2000;2(3):203-10. doi: 10.1186/bcr55. Epub 2000 Mar 7. Breast Cancer Res. 2000. PMID: 11250711 Free PMC article. Review.
Cited by
-
Identification and functional characterization of paxillin as a target of protein tyrosine phosphatase receptor T.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2592-7. doi: 10.1073/pnas.0914884107. Epub 2010 Jan 21. Proc Natl Acad Sci U S A. 2010. PMID: 20133777 Free PMC article.
-
Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.Clin Cancer Res. 2009 Apr 1;15(7):2361-72. doi: 10.1158/1078-0432.CCR-08-1011. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318490 Free PMC article.
-
The Role of the NF-kappaB Transcriptome and Proteome as Biomarkers in Human Head and Neck Squamous Cell Carcinomas.Biomark Med. 2008;2(4):409-426. doi: 10.2217/17520363.2.4.409. Biomark Med. 2008. PMID: 19444329 Free PMC article.
-
Phosphoproteomics: new insights into cellular signaling.Genome Biol. 2005;6(9):230. doi: 10.1186/gb-2005-6-9-230. Epub 2005 Aug 17. Genome Biol. 2005. PMID: 16168091 Free PMC article. Review.
-
Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.Oncotarget. 2016 Oct 25;7(43):69903-69915. doi: 10.18632/oncotarget.12065. Oncotarget. 2016. PMID: 27655711 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous